AHA 2011 schedule
Here is the page we will use to coordinate the TV events at AHA 2011. Open time slots are indicated below in red.
Filming will take place in the Peabody Hotel. Exact location TBD.
Click on Date for Detailed Schedule
Sunday November 13, 2011
8:00 AM
OPEN TIME SLOT
8:30 AM
OPEN TIME SLOT
9:00 AM
OPEN TIME SLOT
9:30 AM
OPEN TIME SLOT
11:00 AM
11:00 AM - 11:30 AM
- Interviewee: Dr. Holger Thiele
- Topic: Intracoronary compared with intravenous bolus abciximab application during primary percutaneous coronary intervention: AIDA STEMI trial
- Embargo lift: 3:45 PM on Sunday, November 13, 2011
11:30 AM
11:30 AM - 12:00 PM
- Interviewee: Dr. Gregg Stone
- Topic: ADAPT-DES: A Large-Scale, Prospective, Multicenter Registry Examining the Relationship of Platelet Responsiveness to Stent Thrombosis After DES Implantation
1:00 PM
OPEN TIME SLOT
1:30 PM
OPEN TIME SLOT
2:00 PM
OPEN TIME SLOT
2:30 PM
OPEN TIME SLOT
3:00 PM
3:00 PM - 3:30 PM
- Interviewee: Dr. Jens Cosedis Nielsen
- Topic: A randomized multicenter comparison of radiofrequency ablation and antiarrhythmic drug therapy as first-line treatment in 294 patients with paroxysmal atrial fibrillation
- Embargo lift: 4:29 PM on Monday, November 14, 2011
3:30 PM
OPEN TIME SLOT
Monday November 14, 2011
8:00 AM
OPEN TIME SLOT
8:30 AM
8:30 AM - 9:00 AM
- Interviewee: Dr. Freek W.A. Verheugt, Dr. Jan Hein Cornel and Dr. Ton Oude Ophuis
- Topic: AHA Wrap-Up from a Dutch Perspective
9:00 AM
9:00 AM - 9:30 AM
- Interviewee: Dr. Peter Kowey
- Topic: Double-blind placebo controlled dose ranging study of the efficacy and safety of celivarone 50, 100, or 300 mg od with amiodarone as calibrator for the prevention of ICD interventions or death (ALPHEE)
- Embargo lift: 3:45 PM on Monday, November 14, 2011
9:30 AM
9:30 AM - 10:00 AM
- Interviewee: Dr. Lucas Boersma
- Topic: Atrial fibrillation catheter ablation vs surgical ablation treatment: A multicenter randomized clinical trial
- Embargo lift: 4:07 PM on Monday, November 14, 2011
2:30 PM
2:30 PM - 3:00 PM
- Interviewee: Dr. John Spertus
- Topic: Testing an evidence-based, individualized informed-consent form to improve patients' experiences with PCI
- Embargo lift: 11:29 AM on Monday, November 14, 2011
3:00 PM
3:00 PM - 3:30 PM
- Interviewee: Dr. Basil Lewis
- Topic: AHA Wrap-Up in Hebrew
3:30 PM
3:30 PM - 4:00 PM
- Interviewee: Dr. Kenneth Mahaffey
- Topic: The Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome (TRA-CER) trial
- Embargo lift: 4:51 PM on Sunday, November 13, 2011
4:00 PM
4:00 PM - 4:30 PM
- Interviewee: Dr. Samuel Goldhaber
- Topic: Extended anticoagulant prophylaxis in initially hospitalized medically ill patients: Results of the ADOPT (Apixaban Dosing to Optimize Protection from Thrombosis) trial
- Embargo lift: 4:29 PM on Sunday, November 13, 2011
4:30 PM
OPEN TIME SLOT
5:00 PM
5:00 PM - 5:30 PM
- Interviewee: Dr. Niteesh Choudhry
- Topic: The impact of full coverage for preventive medications after myocardial infarction on recurrent vascular events: The Post-MI Free Rx Event and Economic Evaluation (Post-MI FREEE) trial
- Embargo lift: 10:45 AM on Monday, November 14, 2011
5:30 PM
5:30 PM - 6:00 PM
- Interviewee: Dr. Gilles Montalescot
- Topic: AHA Wrap-Up in French
Tuesday November 15, 2011
8:00 AM
8:00 AM - 8:30 AM
- Interviewee: Dr. Paul Armstrong
- Topic: AHA Wrap-Up from a Canadian Perspective
8:30 AM
8:30 AM - 9:00 AM
- Interviewee: Dr. Timothy Murphy
- Topic: Claudication treatment comparative effectiveness: Six-month outcomes from the CLEVER study
- Embargo lift: 11:07 AM on Wednesday, November 16, 2011
10:30 AM
10:30 AM - 11:00 AM
- Interviewee: Dr. Adnan Kastrati
- Topic: Abciximab plus unfractionated heparin vs bivalirudin in patients with non-ST-segment-elevation myocardial infarction undergoing percutaneous coronary intervention. The ISAR-REACT 4 randomized trial
- Embargo lift: 4:07 PM on Sunday, November 13, 2011
11:00 AM
OPEN TIME SLOT
11:30 AM
OPEN TIME SLOT
1:30 PM
OPEN TIME SLOT
2:00 PM
OPEN TIME SLOT
2:30 PM
2:30 PM - 3:00 PM
- Interviewee: Dr. William Boden
- Topic: Extended-release niacin does not reduce clinical events in patients with established cardiovascular disease whose LDL cholesterol is optimally controlled with statin therapy: Results from the AIM-HIGH trial
- Embargo lift: 11:51 AM on Tuesday, November 15, 2011
3:00 PM
3:00 PM - 3:30 PM
- Interviewee: Dr. Sergio Leonardi
- Topic: AHA Wrap-Up in Italian
3:30 PM
OPEN TIME SLOT
4:00 PM
OPEN TIME SLOT
4:30 PM
4:30 PM - 5:00 PM
- Interviewee: Dr. Lars Wallentin
- Topic: AHA Wrap-Up from a Scandinavian Perspective
5:00 PM
OPEN TIME SLOT
5:30 PM
5:30 PM - 6:00 PM
- Interviewee: Dr. Stephen Nicholls
- Topic: Comparison of the progression of coronary atherosclerosis for two high-efficacy statin regimens with different HDL effects: SATURN study results
- Embargo lift: 11:07 AM on Tuesday, November 15, 2011
- Topic: Lipid-modulating effects of evacetrapib, a novel CETP inhibitor, administered as monotherapy or in combination with the most commonly used statins
- Embargo lift: 11:29 AM on Tuesday, November 15, 2011